Blood Screening Market Analysis by Product & Service (Reagents and Kits, Instruments, Software & Services), by Technology (ELISA, Nucleic Acid Amplification Test (NAT), Western Blot Assays, Next-Generation Sequencing (NGS), and by Region - Forecast to 2029

Request Sample Page

The global blood screening market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Increase in demand for donated blood and rise in number of blood donations is a key driver for the growth of the global blood screening market. Additionally, rise in global cases of infectious diseases and the occurrence of newer pathogens and rise in favourable initiatives taken by government are some of the other drivers propelling the market growth. Nevertheless, high cost of blood screening and demand for reducing blood screening prices are expected to restrain the global market growth.

Global Blood Screening Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product & Service

Based on product & service, the market is segmented into reagents and kits, ELISA reagents and kits, NAT reagents and kits, other reagents and kits, instruments, rental purchase, outright purchase, and software & services. In 2021, the reagents & kits segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to widespread use of these products as they offer higher accurateness and specificity by detecting presence and type of various elements worldwide. Instruments segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the introduction of new technologies being launched in the global market.

By Technology

Based on technology, the market is segmented into ELISA, nucleic acid amplification test (NAT), western blot assays, rapid tests, and next-generation sequencing (NGS). In 2021, the nucleic acid amplification test (NAT) segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to this technology segment offering high specificity and sensitivity for viral nucleic acid worldwide. ELISA segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the continuous improvement to surge its specificity and low cost in comparison to NAT, along with the increase in occurrence of infectious diseases.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in adoption of blood screening procedure, severe FDA regulations related for transfusion, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increase in awareness among individuals related to blood donation, rise in patient affordability, and increasing focus of key market players in various countries in this region are the major factors in this region.

Competitor Insights

Some of the key players in the blood screening market are Grifols (Spain); Abbott Laboratories (U.S.); Bio-Rad Laboratories (U.S.); Siemens Healthineers (Germany); Danaher Corporation (U.S.); Thermo Fisher Scientific Inc. (U.S.); F. Hoffmann-La Roche AG (Switzerland); BioMérieux (France); Ortho Clinical Diagnostics, Inc. (U.S.); and Becton, Dickinson and Company (U.S.). The leading players operating in the blood screening industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The blood screening market report is categorized into the following segments and subsegments:

Blood Screening Market, By Product & Service (Revenue, USD Billion, 2021 – 2029)

  • Reagents and Kits
  • ELISA Reagents and Kits
    • Immunosorbents
    • Controls
    • Conjugates
    • Substrates
    • Sample Diluents and Wash Solutions
  • NAT Reagents and Kits
    • Enzymes and Polymerases
    • Standards and Controls
    • Probes and Primers
    • Buffers, Nucleotides, and Solutions
    • Labeling and Detection Reagents
  • Other Reagents and Kits
  • Instruments
  • Rental Purchase
  • Outright Purchase
  • Software and Services

Blood Screening Market, By Technology (Revenue, USD Billion, 2021 – 2029)

  • ELISA
    • Chemiluminescent Immunoassay
    • Fluorescent immunoassay
    • Colorimetric Immunoassay
  • Nucleic Acid Amplification Test (NAT)
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • Western Blot Assays
  • Rapid Tests
  • Next-Generation Sequencing (NGS)

Blood Screening Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Blood Screening Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Blood Screening Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Blood Screening
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Blood Screening Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product & Service
    1. Reagents and Kits
      1. Reagents and Kits Market Forecast, 2021-2029 (USD Million)
    2. ELISA Reagents and Kits
      1. ELISA Reagents and Kits Market Forecast, 2021-2029 (USD Million)
    3. NAT Reagents and Kits
      1. NAT Reagents and Kits Market Forecast, 2021-2029 (USD Million)
    4. Other Reagents and Kits
      1. Other Reagents and Kits Market Forecast, 2021-2029 (USD Million)
    5. Instruments
      1. Instruments Market Forecast, 2021-2029 (USD Million)
    6. Rental Purchase
      1. Rental Purchase Market Forecast, 2021-2029 (USD Million)
    7. Outright Purchase
      1. Outright Purchase Market Forecast, 2021-2029 (USD Million)
    8. Software and Services
      1. Software and Services Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Technology
    1. ELISA
      1. ELISA Market Forecast, 2021-2029 (USD Million)
    2. Nucleic Acid Amplification Test (NAT)
      1. Nucleic Acid Amplification Test (NAT) Market Forecast, 2021-2029 (USD Million)
    3. Western Blot Assays
      1. Western Blot Assays Market Forecast, 2021-2029 (USD Million)
    4. Rapid Tests
      1. Rapid Tests Market Forecast, 2021-2029 (USD Million)
    5. Next-Generation Sequencing (NGS)
      1. Next-Generation Sequencing (NGS) Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Blood Screening Market
    1. North America Blood Screening Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
      2. S. Blood Screening Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Canada Blood Screening Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
  1. Europe Blood Screening Market
    1. Europe Blood Screening Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
      2. Germany Blood Screening Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. UK Blood Screening Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. France Blood Screening Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Spain Blood Screening Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Italy Blood Screening Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Rest of Europe Blood Screening Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
  1. Asia Pacific Blood Screening Market
    1. Asia Pacific Blood Screening Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
      2. Japan Blood Screening Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. China Blood Screening Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. India Blood Screening Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. South Korea Blood Screening Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Blood Screening Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Blood Screening Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
  1. Latin America Blood Screening Market
    1. Latin America Blood Screening Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
      2. Brazil Blood Screening Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Mexico Blood Screening Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Argentina Blood Screening Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Rest of Latin America Blood Screening Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
  1. MEA Blood Screening Market
    1. MEA Blood Screening Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
      2. GCC Blood Screening Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. South Africa Blood Screening Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Rest of MEA Blood Screening Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product & Service, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Grifols (Spain)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    2. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    3. Bio-Rad Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    4. Siemens Healthineers (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    5. Danaher Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    6. Thermo Fisher Scientific Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    7. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    8. BioMérieux (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    9. Ortho Clinical Diagnostics, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    10. Becton, Dickinson and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product & Service Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports